{"transactions":[{"id":1800925,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":110383,"kind":"organization","name":"Ayabudge LLC","position":1,"cik":"0001878024","reported_name":"Ayabudge LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-08-21T18:07:15.000Z","date":"2023-08-21","kind":"sale","planned":false,"acquired":false,"shares":602443,"price":3.39,"value":2042281.77,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Between August 17, 2023 and August 21, 2023, the Reporting Person sold 1,799,596 shares of Common Stock. The transactions enabled Mr. Brady W. Dougan, a person controlling the Reporting Person, to pay down leverage while providing a mechanism for investors to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $3.22 to $3.80. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":8191140,"source":{"system":"sec-edgar","filing":"0001818382-23-000119","document":"wf-form4_169265561875582.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1878024/000181838223000119/wf-form4_169265561875582.xml","form_type":"4"}},{"id":1800924,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":110383,"kind":"organization","name":"Ayabudge LLC","position":1,"cik":"0001878024","reported_name":"Ayabudge LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-08-21T18:07:15.000Z","date":"2023-08-18","kind":"sale","planned":false,"acquired":false,"shares":626979,"price":3.57,"value":2238315.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Between August 17, 2023 and August 21, 2023, the Reporting Person sold 1,799,596 shares of Common Stock. The transactions enabled Mr. Brady W. Dougan, a person controlling the Reporting Person, to pay down leverage while providing a mechanism for investors to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $3.50 to $3.75. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":8793583,"source":{"system":"sec-edgar","filing":"0001818382-23-000119","document":"wf-form4_169265561875582.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878024/000181838223000119/wf-form4_169265561875582.xml","form_type":"4"}},{"id":1800923,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":110383,"kind":"organization","name":"Ayabudge LLC","position":1,"cik":"0001878024","reported_name":"Ayabudge LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-08-21T18:07:15.000Z","date":"2023-08-17","kind":"sale","planned":false,"acquired":false,"shares":570174,"price":3.68,"value":2098240.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Between August 17, 2023 and August 21, 2023, the Reporting Person sold 1,799,596 shares of Common Stock. The transactions enabled Mr. Brady W. Dougan, a person controlling the Reporting Person, to pay down leverage while providing a mechanism for investors to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $3.50 to $4.13. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":9420562,"source":{"system":"sec-edgar","filing":"0001818382-23-000119","document":"wf-form4_169265561875582.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878024/000181838223000119/wf-form4_169265561875582.xml","form_type":"4"}},{"id":1852670,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":110383,"kind":"organization","name":"Ayabudge LLC","position":1,"cik":"0001878024","reported_name":"Ayabudge LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T16:04:22.000Z","date":"2023-06-15","kind":"sale","planned":false,"acquired":false,"shares":500000,"price":3.1175,"value":1558750.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2023, the Reporting Person sold 500,000 shares of Common Stock. The transactions enabled Mr. Brady W. Dougan, a person controlling the Reporting Person, to pay down leverage while providing a mechanism for the institutional healthcare investor purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase."}],"balance_after":9990736,"source":{"system":"sec-edgar","filing":"0001818382-23-000081","document":"wf-form4_168694584708349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878024/000181838223000081/wf-form4_168694584708349.xml","form_type":"4"}},{"id":1854673,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":110383,"kind":"organization","name":"Ayabudge LLC","position":1,"cik":"0001878024","reported_name":"Ayabudge LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T16:17:40.000Z","date":"2023-06-13","kind":"sale","planned":false,"acquired":false,"shares":4875000,"price":2.6,"value":12675000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 13, 2023, the Reporting Person sold 4,875,000 shares of Common Stock. The transactions enabled Mr. Brady W. Dougan, a person controlling the Reporting Person, to pay down leverage while providing a mechanism for the institutional healthcare investor purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase."}],"balance_after":10490736,"source":{"system":"sec-edgar","filing":"0001818382-23-000047","document":"wf-form4_168686024922892.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878024/000181838223000047/wf-form4_168686024922892.xml","form_type":"4"}},{"id":1876768,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":110383,"kind":"organization","name":"Ayabudge LLC","position":1,"cik":"0001878024","reported_name":"Ayabudge LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-26T17:02:14.000Z","date":"2023-05-25","kind":"sale","planned":false,"acquired":false,"shares":2625000,"price":2.75,"value":7218750.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 25, 2023, the Reporting Person sold 2,625,000 shares of Common Stock. The transactions enabled Mr. Brady W. Dougan, a person controlling the Reporting Person, to pay down leverage while providing a mechanism for the institutional healthcare investor purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase."}],"balance_after":15365736,"source":{"system":"sec-edgar","filing":"0001104659-23-065543","document":"tm2317123-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878024/000110465923065543/tm2317123-7_4seq1.xml","form_type":"4"}},{"id":2082031,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":110383,"kind":"organization","name":"Ayabudge LLC","position":1,"cik":"0001878024","reported_name":"Ayabudge LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-19T20:19:36.000Z","date":"2022-12-16","kind":"sale","acquired":false,"shares":239538,"price":2.53,"value":606031.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 16, 2022, the Reporting Person sold 239,538 shares of Common Stock. The transactions enabled Mr. Brady W. Dougan, a person controlling the Reporting Person, to pay down leverage while providing a mechanism for the purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase. Mr. Dougan, directly and indirectly, remains the largest shareholder of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.50 to $2.63. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":17990736,"source":{"system":"sec-edgar","filing":"0001818382-22-000219","document":"wf-form4_167149916039845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878024/000181838222000219/wf-form4_167149916039845.xml","form_type":"4"}},{"id":2085294,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":110383,"kind":"organization","name":"Ayabudge LLC","position":1,"cik":"0001878024","reported_name":"Ayabudge LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-15T19:46:49.000Z","date":"2022-12-15","kind":"sale","acquired":false,"shares":93426,"price":2.63,"value":245710.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 13, 14 and 15, 2022, the Reporting Person sold 330,000, 276,304 and 93,426 shares of Common Stock, respectively. The transactions enabled Mr. Brady W. Dougan, a person controlling the Reporting Person, to pay down leverage while providing a mechanism for the purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase. Mr. Dougan, directly and indirectly, remains the largest shareholder of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.60 to $2.80. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18230274,"source":{"system":"sec-edgar","filing":"0001818382-22-000209","document":"wf-form4_167115157790775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1878024/000181838222000209/wf-form4_167115157790775.xml","form_type":"4"}},{"id":2085293,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":110383,"kind":"organization","name":"Ayabudge LLC","position":1,"cik":"0001878024","reported_name":"Ayabudge LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-15T19:46:49.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":276304,"price":2.76,"value":762599.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 13, 14 and 15, 2022, the Reporting Person sold 330,000, 276,304 and 93,426 shares of Common Stock, respectively. The transactions enabled Mr. Brady W. Dougan, a person controlling the Reporting Person, to pay down leverage while providing a mechanism for the purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase. Mr. Dougan, directly and indirectly, remains the largest shareholder of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.75 to $2.87. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18323700,"source":{"system":"sec-edgar","filing":"0001818382-22-000209","document":"wf-form4_167115157790775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878024/000181838222000209/wf-form4_167115157790775.xml","form_type":"4"}},{"id":2085292,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":110383,"kind":"organization","name":"Ayabudge LLC","position":1,"cik":"0001878024","reported_name":"Ayabudge LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-15T19:46:49.000Z","date":"2022-12-13","kind":"sale","acquired":false,"shares":330000,"price":2.84,"value":937200.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 13, 14 and 15, 2022, the Reporting Person sold 330,000, 276,304 and 93,426 shares of Common Stock, respectively. The transactions enabled Mr. Brady W. Dougan, a person controlling the Reporting Person, to pay down leverage while providing a mechanism for the purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase. Mr. Dougan, directly and indirectly, remains the largest shareholder of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.77 to $3.06. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18600004,"source":{"system":"sec-edgar","filing":"0001818382-22-000209","document":"wf-form4_167115157790775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878024/000181838222000209/wf-form4_167115157790775.xml","form_type":"4"}},{"id":2156021,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":110383,"kind":"organization","name":"Ayabudge LLC","position":1,"cik":"0001878024","reported_name":"Ayabudge LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-19T16:33:02.000Z","date":"2022-09-15","kind":"sale","acquired":false,"shares":1522500,"price":4,"value":6090000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was made by the Reporting Person in a block trade. The purchaser is an existing investor of the Issuer, who had previously participated in the Issuer's PIPE financing transaction, and was interested in increasing its ownership of the Humacyte, Inc. The transaction enabled Mr. Brady Dougan, a person controlling the Reporting Person, to pay down leverage while providing a mechanism for the purchaser to acquire a large block of shares at a time that Humacyte, Inc. was not conducting a financing and was not making any additional shares available for purchase. Mr. Dougan, directly and indirectly, remains the largest shareholder of the Issuer."}],"balance_after":18930004,"source":{"system":"sec-edgar","filing":"0001818382-22-000159","document":"wf-form4_166361956732744.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878024/000181838222000159/wf-form4_166361956732744.xml","form_type":"4"}},{"id":2588549,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":110383,"kind":"organization","name":"Ayabudge LLC","position":1,"cik":"0001878024","reported_name":"Ayabudge LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-27T16:13:06.000Z","date":"2021-08-26","kind":"purchase","acquired":true,"shares":1522500,"price":10,"value":15225000.0,"ownership":{"direct":true},"balance_after":20452504,"source":{"system":"sec-edgar","filing":"0001104659-21-110538","document":"tm2125954-22_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878024/000110465921110538/tm2125954-22_4seq1.xml","form_type":"4"}},{"id":2588548,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":110383,"kind":"organization","name":"Ayabudge LLC","position":1,"cik":"0001878024","reported_name":"Ayabudge LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-27T16:13:06.000Z","date":"2021-08-26","kind":"grant","acquired":true,"shares":18930004,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 26, 2021, Alpha Health care Acquisition Corp. (\"AHAC\") consummated a business combination (the \"Business Combination\") by and among AHAC, Hunter Merger Sub, Inc., a Delaware corporation (\"Hunter Merger Sub\") and Humacyte, Inc., a Delaware corporation (\"Legacy Humacyte\"), AHAC changed its name to \"Humacyte, Inc.\" and Hunter Merger Sub merged with and into Legacy Humacyte. As part of the Business Combination, each share of Legacy Humacyte stock was exchanged for 0.2626 shares of common stock of Humacyte, Inc."}],"balance_after":18930004,"source":{"system":"sec-edgar","filing":"0001104659-21-110538","document":"tm2125954-22_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878024/000110465921110538/tm2125954-22_4seq1.xml","form_type":"4"}}]}